Why PCOS Was Changed to PMOS In 2026? What the New Name Means for Women

PCOS was changed to PMOS because the new name more accurately describes the condition as a complex hormonal, metabolic and ovarian disorder rather than a problem defined by ovarian cysts. The condition previously called Polycystic Ovary Syndrome (PCOS) is now known as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change was announced on May 12, 2026 following years of international consultation involving healthcare professionals, researchers, advocacy organisations and women living with the condition.

Understanding why PCOS was changed to PMOS is important for women who have already been diagnosed, those currently experiencing unexplained symptoms and healthcare professionals responsible for diagnosis and treatment. Although the name has changed, women should not panic or assume that they have developed a different condition. PCOS and PMOS refer to the same underlying syndrome.

The new name shifts attention away from ovarian “cysts” and towards the broader hormonal and metabolic effects that can influence menstrual cycles, ovulation, insulin function, weight, skin, hair, emotional wellbeing and long-term health. During the transition, many healthcare providers and patients may use the phrase “PCOS, now called PMOS” while medical records, educational materials and public awareness catch up with the updated terminology.

PCOS Is Now Called PMOS

Polycystic Ovary Syndrome, commonly abbreviated as PCOS, is now called Polyendocrine Metabolic Ovarian Syndrome, or PMOS. This new terminology was chosen to give women and healthcare providers a clearer understanding of what the condition actually involves.

For decades, the term PCOS caused confusion because it appeared to describe a condition centered on cysts in the ovaries. In reality, ovarian cysts are not required for every diagnosis, and the small structures that may appear on an ultrasound are usually ovarian follicles rather than true cysts.

PCOS, now called PMOS, is better understood as a condition involving multiple hormonal systems, metabolic function and ovarian health. Its effects can extend beyond the reproductive system and may change throughout a woman’s life.

The name change is expected to be introduced gradually. Women may therefore continue seeing PCOS on previous medical records, laboratory requests, insurance documents, prescriptions and older health information. This does not mean that their diagnosis is no longer valid.

For women searching online, both terms will remain relevant for some time. Using “PCOS, now called PMOS” helps patients connect familiar information with the updated medical language.

What Does PMOS Stand For?

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. Each word was deliberately selected to communicate an important part of the condition.

“Polyendocrine” means that multiple hormones or endocrine pathways may be involved. PMOS is not simply an ovarian problem. It may involve androgens, insulin and other hormonal signals that influence menstrual cycles, ovulation, skin, hair, energy use and body composition.

“Metabolic” recognises the relationship between the condition and the way the body processes and uses energy. Some women with PMOS experience insulin resistance, meaning the body does not respond to insulin as effectively as it should. This can lead the body to produce more insulin and may contribute to hormonal changes. Not every woman with PMOS is overweight or has insulin resistance, so individual assessment remains essential.

“Ovarian” acknowledges that ovarian function is still an important part of the syndrome. Women may experience irregular ovulation, infrequent periods, absent periods or changes in ovarian follicle development.

“Syndrome” means a group of signs, symptoms and health features that may occur together. Two women with PMOS may have very different experiences. One may seek help for irregular periods and acne, while another may be concerned about unwanted facial hair, weight changes or difficulty with ovulation.

Understanding what PMOS stands for helps answer why PCOS was changed to PMOS. The updated name provides a more complete description without suggesting that every woman must have the same symptoms.

Why Was PCOS Renamed?

PCOS was renamed because the former name was considered medically incomplete and potentially misleading. It focused too heavily on ovarian appearance while failing to represent the syndrome’s wider endocrine, metabolic, reproductive, dermatological and psychological effects.

The decision followed years of discussion among international experts, healthcare professionals, researchers, patient advocates and women with lived experience. The aim was not to create a new disease. It was to give an existing condition a more accurate and useful name.

One reason why PCOS was changed to PMOS was the persistent misconception that a woman must have ovarian cysts to receive a diagnosis. Some women were told they could not have PCOS because an ultrasound did not show “cysts.” Others were diagnosed based mainly on ovarian appearance even when a full clinical assessment was needed.

The old name could also cause women and healthcare providers to concentrate primarily on menstruation, ovulation and fertility. These areas are important, but PCOS, now called PMOS, can also be associated with metabolic risks, skin changes and emotional health concerns.

Renaming the condition may encourage a more complete assessment. Instead of asking only whether cysts are visible, healthcare providers can consider menstrual history, signs of androgen excess, relevant blood tests, metabolic health, family history, emotional wellbeing and other possible causes of the symptoms.

The answer to why PCOS was changed to PMOS is therefore accuracy. PMOS describes more of the condition, acknowledges that it can affect several body systems and reduces the misleading emphasis on cysts.

Why the Word “Cystic” Was Misleading

The word “cystic” was misleading because many women with the syndrome do not have ovarian cysts, and the structures commonly seen on ultrasound are usually small, immature follicles rather than true cysts.

A follicle is a normal fluid-filled structure in the ovary that contains an immature egg. In women with PCOS, now called PMOS, several follicles may remain at an early stage of development when ovulation does not occur regularly. On an ultrasound, these follicles may create a characteristic ovarian appearance, but they are not necessarily harmful cysts that require surgical removal.

A woman can meet the diagnostic criteria for PMOS without having polycystic ovarian morphology on an ultrasound. Similarly, a woman may have ovaries that appear polycystic without having the full syndrome. Ovarian appearance must therefore be interpreted alongside symptoms, medical history and other clinical findings.

The former terminology sometimes caused unnecessary fear. Hearing the words “polycystic ovaries” could make a patient imagine large, dangerous growths or assume that surgery was needed. It could also make her believe that the condition existed only in the ovaries.

Removing “cystic” from the name helps separate PMOS from unrelated ovarian cysts. It also supports clearer conversations between patients and healthcare professionals.

This is one of the clearest reasons why PCOS was changed to PMOS. The updated terminology is intended to reduce confusion and support more accurate diagnosis.

How PMOS Reflects Hormonal and Metabolic Health

The term PMOS recognises that the syndrome involves interconnected hormonal and metabolic processes. Hormones act as chemical messengers throughout the body, meaning that an imbalance in one pathway can affect several areas of health.

Some women with PMOS have elevated androgen levels or physical signs of androgen excess. These may include persistent acne, increased facial or body hair, or thinning hair on the scalp. Other women may have irregular or absent menstrual periods because ovulation is not occurring consistently.

Metabolic health is another important part of the condition. Insulin resistance may be present even when a woman does not have obesity. When cells respond poorly to insulin, the body may produce additional insulin to keep blood glucose within an appropriate range. Higher insulin levels can interact with ovarian hormone production and contribute to the symptoms experienced by some women.

PMOS may also be associated with an increased risk of prediabetes, type 2 diabetes, abnormal cholesterol levels, high blood pressure and other cardiometabolic concerns. Having PMOS does not mean that a woman will automatically develop these conditions. It means that appropriate screening, personalised prevention and regular follow-up may be beneficial.

Mental and emotional wellbeing should not be overlooked. Some women experience anxiety, depression, body-image concerns, eating difficulties or distress related to symptoms. Compassionate care should acknowledge these concerns instead of treating PMOS as a cosmetic or reproductive problem only.

The new name encourages healthcare professionals to look beyond the ovaries and consider the whole patient. That broader perspective is central to understanding why PCOS was changed to PMOS.

Did the Diagnostic Criteria Change?

The name change itself does not automatically invalidate established diagnostic criteria or require women to be diagnosed again. PCOS, now called PMOS, remains a clinical diagnosis based on a combination of relevant features after other possible causes have been considered.

Depending on a patient’s age and circumstances, an assessment may include menstrual history, evidence of irregular ovulation, clinical or biochemical signs of higher androgen activity and ovarian morphology. A healthcare professional may also request blood tests or other investigations to rule out thyroid disorders, elevated prolactin, non-classic congenital adrenal hyperplasia and other conditions that can produce similar symptoms.

Ultrasound is not required in every situation. It should not be treated as the only way to confirm or exclude PMOS. The approach may also differ for adolescents because irregular cycles, acne and hormonal changes can occur naturally during puberty. Careful evaluation is needed to avoid both missed diagnoses and overdiagnosis.

Women should not diagnose themselves from one symptom, a single hormone result or an ultrasound report. Symptoms vary, and other medical conditions may overlap with PMOS.

As clinical guidance evolves, healthcare providers may receive updated recommendations on terminology and assessment. However, the main purpose of the rename is to describe the syndrome more accurately, not to erase previous diagnoses.

Does the Name Change Affect Treatment?

The name change does not mean that every woman must stop her current treatment or begin a new medication. Treatment remains personalised according to symptoms, medical history, health risks, age, priorities and pregnancy plans.

Management may include support for menstrual regularity, androgen-related symptoms, metabolic health, emotional wellbeing or ovulation. A clinician may recommend nutrition and physical activity strategies, medication or targeted treatment depending on the individual’s needs.

There is no single PMOS treatment that is suitable for every woman. Hormonal contraception may be considered for some patients who are not trying to conceive and want support with menstrual regularity or androgen-related symptoms. Metformin may be appropriate in selected cases; particularly where metabolic concerns are present. Other treatments may be considered for acne, unwanted hair growth or scalp hair thinning.

Lifestyle support should be realistic, respectful and free from blame. PMOS can affect women across different body sizes. Care should focus on sustainable health behaviours, metabolic wellbeing and achievable goals rather than assuming that weight loss is the only solution.

Women should not stop prescribed medication because the condition has a different name. Anyone concerned about her treatment should consult a qualified healthcare professional for an individual review.

What Does the Change Mean for Women Already Diagnosed With PCOS?

For women already diagnosed with PCOS, the change to PMOS does not mean that the original diagnosis was erased. Your records, previous test results, prescriptions and treatment history remain important.

You do not usually need to repeat every investigation simply because the terminology changed. At your next appointment, you can ask whether your records will use PMOS, PCOS or both terms during the transition.

The new name may help you have more complete discussions about your health. In addition to periods and ovarian symptoms, you can ask about blood glucose, cholesterol, blood pressure, emotional wellbeing, skin and hair concerns, sleep, family history and any changes in your symptoms.

Women should also know that PMOS can evolve across different stages of life. Symptoms and priorities during adolescence may differ from those experienced while planning a pregnancy or approaching menopause. Ongoing care should reflect these changing needs.

Most importantly, the rename may provide validation. Women who felt that the term PCOS did not describe their experience now have language that better acknowledges the syndrome’s wider impact.

PMOS and Fertility

PMOS can affect ovulation and fertility, but it does not automatically mean that a woman cannot become pregnant. Many women with PCOS, now called PMOS, conceive naturally or with appropriate medical support.

Because detailed fertility guidance deserves focused explanation, read our complete guide, “PMOS and Fertility: Can PMOS Affect Pregnancy?” for more information about ovulation, conception, pregnancy planning and available support.

Frequently Asked Questions About Why PCOS Was Changed to PMOS

1. When was PCOS officially changed to PMOS?

The name change was announced on May 12, 2026 after an international process involving researchers, medical organisations, health professionals, advocacy groups and women with lived experience. Adoption will take time, so patients may continue seeing both names in medical records and online health information.

2. Are PCOS and PMOS the same condition?

Yes. PCOS and PMOS describe the same underlying syndrome. PMOS is not a new illness, a more severe stage of PCOS or a separate diagnosis. The updated name provides a more accurate description of the condition’s hormonal, metabolic and ovarian features.

3. Do I need a new diagnosis if I was previously diagnosed with PCOS?

Most women will not need a completely new diagnosis solely because the name changed. Previous medical records and test results remain relevant. However, regular reviews may still be recommended to assess symptoms, treatment effectiveness and metabolic health. Speak with your healthcare provider if your symptoms have changed or your original diagnosis was uncertain.

4. Can I have PMOS if my ultrasound does not show ovarian cysts?

Yes. A woman may have PMOS without ovarian cysts or polycystic ovarian morphology. Diagnosis is based on an appropriate combination of clinical findings, symptoms and investigations after other possible causes have been excluded. Ultrasound should not be used as the only diagnostic test.

5. Does PMOS only affect women who are overweight?

No. PMOS can affect women across different body sizes. Some women have insulin resistance or other metabolic concerns without being overweight. Others may not show obvious metabolic changes. Every patient deserves an individual assessment rather than assumptions based on appearance or body weight.

6. Should I stop my PCOS medication now that the name has changed?

No. Do not stop medication or change your treatment simply because PCOS is now called PMOS. The rename does not make your prescription ineffective. Continue following your clinician’s instructions and arrange a review if you have concerns, side effects, changing symptoms or new pregnancy plans.

Conclusion

PCOS was changed to PMOS because Polyendocrine Metabolic Ovarian Syndrome describes the condition more accurately than Polycystic Ovary Syndrome. The former name placed too much emphasis on ovarian cysts even though cysts are not required for diagnosis and the structures seen on ultrasound are often follicles rather than true cysts.

PMOS better reflects the condition’s hormonal, metabolic and ovarian features, as well as its possible effects on menstrual cycles, skin, hair, emotional wellbeing and long-term health. The name change does not create a new disease, cancel an existing PCOS diagnosis or automatically change a woman’s treatment.

Women already diagnosed with PCOS can continue their prescribed care and discuss the updated terminology during future appointments. As medical systems transition, “PCOS, now called PMOS” will remain useful for connecting familiar language with the new name.

If you have irregular periods, persistent acne, unwanted facial hair, unexplained weight changes, difficulty with ovulation or concerns about PMOS, professional evaluation can help you understand your symptoms and receive personalised care.

Contact Nectar Gyn & Fertility Centre for compassionate, confidential and individualised women’s healthcare.

Call +254 (0) 112 792 444 or +254 (0) 118 141 000 to schedule your consultation.